Reta is the nickname for retatrutide, a triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. Phase 2 trials showed 24.2% average body weight loss. Here's what the data shows and how to access it.
Retatrutide is an new drug that has shown promise in the treatment of obesity and type 2 diabetes. Retatrutide is a type of multi-receptor agonist that targets multiple hormonal pathways involved in blood sugar regulation, appetite control and metabolic health.
With thousands of hotels worldwide, booking cheap hotels and accommodations with Expedia is simple and rewarding. As an Expedia member you get more than just a booking discount, you get points towards your next trip too.
Search and compare 840 hotels in Hong Kong for the best hotel deals at momondo. Find the cheapest prices for luxury, boutique, or budget hotels in Hong Kong
Find Cheap Hotels & Motels Near You. Get the best hotel room from 1 million hotels and motels worldwide with rooms ranked by hundreds of millions of reviews and opinions from Tripadvisor travellers.
Frequently asked questions and answers about Lilly’s retatrutide, an investigational, once-weekly injectable medication that is being studied for the treatment of obesity.
Current FDA approval status, regulatory history, and clinical trial results for retatrutide, an investigational treatment for obesity from the development pipeline at Eli Lilly and Company.
Retatrutide is a medication that’s being studied for weight loss and diabetes. Learn more about retatrutide for weight loss.
What is retatrutide? Retatrutide is an experimental injectable weight-loss medication being developed by the pharmaceutical company Eli Lilly. “It is sometimes referred to as a ‘triple-agonist ...